Breadcrumb
- Home
- Publications
- Proceedings
- Metabolic Engineering 11
- General Submissions
- Session 10: Industrial Applications of Metabolic Engineering
- Small Molecule Glycosylation – a Powerhouse in Synthetic Biology
The de-toxification aspect is particularly interesting as this allows for biological production of molecules otherwise harmful to the producing organism but the often accompanying increase in watery solubility can be of equal importance. Obtaining the right functionality of molecules by complex glycosylation is of obvious importance but requires deep knowledge on UGT specificity. Evolva has for many years been developing a state-of-the-art UGT platform and used this for current or near-to-market products such as Vanillin and Stevia sweeteners, but also for a large number of pipeline products.
The use of small molecule glycosylation in current and future Evolva ingredients will be discussed as will a number of the detailed studies that led to the success of the UGT platform.
Hansen, E.H., Møller, B.L., Koch, G., Bünner, C.M., Kristensen, C., Jensen, O.R., Motawia, M.S., Olsen, C.E., Okkels, F.T., & Hansen, J. 2009. De novo biosynthesis of vanillin in fission yeast (Schizosaccharomyces pombe) and baker’s yeast (Saccharomyces cerevisiae). Appl. Env. Microbiol. 75: 2765-2774.
Hansen, E.H., Osmani S.A., Kristensen, C., Møller, B.L. & Hansen, J. 2009. Substrate specificities of family 1 UGTs gained by domain swapping. Phytochemistry 70: 473-482.
Olsson, K., Simon Carlsen, S., Semmler, A., Simon, E., Mikkelsen, M., & Møller, B.L. Microbial production of next-generation Stevia sweeteners. Submitted for publication.